Navigation Links
Finesse Solutions Launches Next Generation SmartGlass 3L Bioreactors for Cell Culture and Fermentation
Date:6/19/2013

SANTA CLARA, Calif., June 19, 2013 /PRNewswire/ -- Finesse Solutions, Inc, a manufacturer of measurement and control solutions for life sciences process applications, announced the launch of its new SmartGlass™ autoclavable 3L glass bioreactors for upstream cell culture and fermentation.  The 3L glass vessels are the first in a new product family of Finesse bioreactors and are designed to optimize yield in both R&D and cGMP applications.  They are fully compatible with all Finesse G3Lab controllers, and with SmartAdapters can be utilized with third party controllers.

Designed for R&D and process development scale-up, SmartGlass vessels enable easier handling and faster assembly/disassembly for cleaning.  They were developed to be fully hygienic to ensure complete process sterility and minimize lost batches.  The vessels are manufactured with the highest standards for surface finish and safety of operation.

"We have made many design improvements to optimize the SmartGlass platform for cell culture and fermentation processes.  For examples, our cold finger has increased surface area to enable faster thermal control and increase cooling capacity so that a single-wall vessel can be used for fermentation.  We have also collaborated closely with the group of Profs. Dieter and Regine Eibl at the University of Wadenswil in Zurich, Switzerland, in order to create a novel impeller design that produces higher average kLa, and increases power transfer while minimizing shear. The vessels have been designed using all of the machinery available for computational fluid mechanics simulations," stated Dr. Mark Selker, Vice President of R&D and co-founder of Finesse Solutions.

About Finesse Solutions, Inc
California-based Finesse Solutions, Inc has established a proven record in providing turn-key, scalable solutions for single-use upstream bio-processing.  The Finesse product platform includes an extensive portfolio of novel disposable sensors, modular configure-to-order automation hardware, and intelligent software that can harmonize global bio-process information and technology transfer.  Finesse also offers a complete set of services including startup, commissioning, and validation for rapid and reliable deployment of single-use equipment into cGMP manufacturing applications. For more information, please visit us at www.finesse.com.


'/>"/>
SOURCE Finesse Solutions, Inc
Copyright©2012 PR Newswire.
All rights reserved

Related medicine technology :

1. Finesse Solutions Turns to HiveMind Marketing to Revitalize Website
2. Finesse Solutions Launches Next Generation G3Lab Universal SmartControllers to Enhance Productivity in Bench Scale Cell Culture and Fermentation
3. SolutionStart Corp. Announces John Karagiannis as Vice President of Technology
4. Cardinal Health Specialty Solutions Launches PathWare™ Decision Support Transaction Solutions
5. At SIIM 2012 Siemens Healthcare Demonstrates Departmental IT Solutions That Help Administrators Increase Access while Managing Costs
6. Cardiosolutions, Inc. Receives FDA 510(k) Clearance for Dexterity™ Steerable Introducer
7. UBM Canon, the Global MedTech Authority, Partners with the World Medical Device Organization, WMDO, to Provide Medical Device Companies with Industry-Related Online Training Solutions
8. Ablative Solutions Completes $5.3M Series A Financing
9. DATATRAK Expands CDISC Registered Solutions Provider Standards
10. MedNet Solutions to Unveil Innovative New iMedNet EDC Features at The 48th DIA Annual Meeting
11. Frazier Healthcare Acquires U.S. Commercial Pharmaceutical Packaging Operations from Catalent Pharma Solutions
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:3/29/2017)... , March 29, 2017  Novartis announced today ... has accepted the company,s Biologics License Application (BLA) ... an investigational chimeric antigen receptor T cell (CAR-T) ... young adult patients with B-cell acute lymphoblastic leukemia ... Novartis for a CAR-T. The priority review designation ...
(Date:3/29/2017)... Research and Markets has announced the addition of the "South ... & Forecast" report to their offering. ... The South Korean Proton Therapy Market is expected to ... Untapped Proton Therapy Market for South Korea was ... Proton Therapy plays an important role in delivering comprehensive cancer care to ...
(Date:3/29/2017)... 29, 2017  Zynex (OTCQB: ZYXI), an innovative medical technology ... medical devices for pain management, stroke rehabilitation, cardiac monitoring ... the Company,s 2016 full-year investor webcast on Monday, April 3, ... The Company expects to file its 2016 full year ... ...
Breaking Medicine Technology:
(Date:3/29/2017)... ... 2017 , ... Patients interested in receiving quick and effective ... Cameron, with or without a referral. The FASTBRACES system is valued for its ... patient’s case, treatment with the FASTBRACES system could be completed in 120 days ...
(Date:3/29/2017)... ANN ARBOR, Mich. (PRWEB) , ... ... ... Global Retailer and Manufacturer Alliance (GRMA) is growing as it continues developing ... the dietary supplement industry. The organization, which plans to publish the first ...
(Date:3/29/2017)... ... March 29, 2017 , ... Altima Technologies, Inc., ... network and data center assets and audio-video devices has recently updated its Visio ... shapes for free and download shapes and stencils from http://www.VisioStencils.com. , ...
(Date:3/29/2017)... ... March 29, 2017 , ... ... oral braces. "The rubber bands used in conjunction with my braces always rubbed ... to design a way to prevent this problem." The O.B.S. was the result ...
(Date:3/29/2017)... ... March 29, 2017 , ... The assembly ... assembly protocols involve many repetitive steps and often scientists require many different versions ... high-throughput needed, and results in a lower error rate and cost saving for ...
Breaking Medicine News(10 mins):